Dysplastic naevi: an update

Histopathology - Tập 56 Số 1 - Trang 112-120 - 2010
David E. Elder1
1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA USA

Tóm tắt

Elder D E
(2010) Histopathology56, 112–120
Dysplastic naevi: an updateDysplastic naevi are clinically atypical and histologically are characterized by architectural disorder and cytological atypia. Their diagnosis is reproducible if criteria and thresholds are agreed upon. They are significant only in relation to melanoma, as simulants of melanoma, as markers of individuals at increased risk of developing melanoma, and as potential and occasional actual precursors of melanoma. Morphologically and biologically, they are intermediate between common naevi and melanoma. Individuals with dysplastic naevi may have deficient DNA repair, and dysplastic naevi lesions are associated with overexpression of pheomelanin, which may lead to increased oxidative damage and increased potential for DNA damage and tumour progression.

Từ khóa


Tài liệu tham khảo

Clark WH, 1978, Origin of familial melanomas from heritable melanocytic lesions. ‘The B‐K mole syndrome’, Arch. Dermatol., 114, 732, 10.1001/archderm.1978.01640170032006

10.1016/S0140-6736(77)92822-7

10.1136/jmg.15.5.352

10.1002/1097-0142(19801015)46:8<1787::AID-CNCR2820460816>3.0.CO;2-S

10.1016/S0140-6736(80)92176-5

10.1111/j.1365-4362.1992.tb03947.x

National Institutes of Health, 1983, Precursors to malignant melanoma, NIH Consens. Statement Online, 4, 14

10.1067/mjd.2002.121029

10.1097/DAD.0b013e318185d205

10.1038/jid.2008.203

10.1038/modpathol.2008.41

10.1097/DAD.0b013e3181584950

10.1097/01.cmr.0000222600.73179.f3

10.1038/sj.jid.5700011

10.1097/00008390-200510000-00008

10.1046/j.0022-202X.2004.22225.x

10.1111/j.0022-202X.2004.23402.x

Dong J, 2003, BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma, Cancer Res., 63, 3883

10.1038/ng1054

10.1038/nature07586

10.1097/PAS.0b013e318057faa7

10.1002/ijc.20325

10.1111/j.1365-2133.2008.08887.x

Omholt K, 2002, Screening of N‐ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression, Clin. Cancer Res., 8, 3468

10.1002/1097-0142(19890315)63:6<1240::AID-CNCR2820630635>3.0.CO;2-9

10.1111/j.1365-2133.1991.tb00424.x

10.1038/modpathol.3800515

Nordlund JJ, 1985, Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects, Cancer Res., 45, 1855

10.3322/canjclin.35.3.130

10.1001/jama.292.22.2771

10.1016/0190-9622(93)70151-I

10.1038/sj.bjc.6603283

10.1001/archderm.141.4.434

10.1001/archderm.134.1.103-a

10.1111/j.1365-2559.1988.tb01943.x

Rhodes AR, 1989, Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology, Mod. Pathol., 2, 306

10.1016/S0959-8049(05)80419-8

10.1016/S0190-9622(08)81499-5

10.1001/archderm.1997.03890440019002

10.1038/jid.2009.5

Elder DE, 2009, Melanocytic tumors of the skin

10.1111/1523-1747.ep13076737

10.1007/BF00372084

10.1097/01.MP.0000082394.91761.E5

10.1111/j.1365-2133.2006.07466.x

10.1309/KXJW-1UJE-BPG6-AXBV

10.1038/jid.1993.55

10.1016/0190-9622(92)70206-U

10.1016/S0046-8177(99)90192-2

10.1093/jnci/83.23.1726

10.1001/archderm.141.8.998

10.1136/jcp.2004.019422

10.1002/ijc.2910300108

10.1159/000249275

10.1111/1523-1747.ep12388847

10.1007/BF01952205

10.1093/jnci/94.2.94

10.1097/00000372-200108000-00006

10.1034/j.1600-0560.2001.280702.x

10.1111/j.1755-148X.2009.00578.x

10.1111/j.1600-0625.2009.00846.x

10.1002/ijc.24327

10.1038/ng.161

10.1038/ng.163

10.1111/j.1600-0749.1991.tb00435.x

10.1016/j.ejca.2003.11.035

10.1111/j.1751-1097.2007.00242.x